申请人:Hoelzemann Guenter
公开号:US20110028472A1
公开(公告)日:2011-02-03
Novel thienopyrimidines of the formula (I), in which R
1
, R
2
and X have the meanings indicated in Claim
1
, are inhibitors of TGF-beta receptor kinase, and can be employed, inter alia, for the treatment of tumours.
化合物(I)的新噻吩嘧啶类化合物,在其中R1、R2和X具有权利要求书中指示的含义,是TGF-beta受体激酶的抑制剂,可用于治疗肿瘤。